Roukaya Al Hammoud, MD, is a board-certified pediatric infectious diseases physician with clinical expertise in general pediatric infections and congenital infections. She is passionate about delivering comprehensive care to children affected by complex infectious diseases, and her work is rooted in evidence-based medicine and compassionate, family-centered care.
Dr. Al Hammoud is engaged in both clinical care and academic research, with a particular focus on infectious disease prevention, global child health, and improving therapeutic approaches through translational research. Her research interests include immune responses to infections and vaccines in the pediatric population and congenital infections. Dr. Al Hammoud is committed to advancing clinical research that informs best practices and improves health outcomes for vulnerable children globally.
General pediatric infectious diseases
Congenital infections
Vaccine responses
Pediatric HIV
Antimicrobial resistance
Al Hammoud A, Aneji C, Heresi G, Murphy J, Perez N. Perinatal HIV-1 Infection in an Extremely Low Birth Weight Infant. The Pediatric Infectious Disease Journal. 2020. doi: 10.1097.
Chong H, Al Hammoud R, Chang ML. Presumptive Dipylidium caninum infection in a toddler. Hindawi. 2020.
Hammoud A, Murphy J, Chang ML. Plasmodium vivax Infection in Multiple Family Members in Texas, USA2019. doi: 10.1155/2019/8568710 PMCID: PMC6590619
Lee K, Heresi G, Al Hammoud R. Norwegian Scabies in a Patient with Down Syndrome. Journal of Pediatrics. 2019;209:253- e1.
Al Hammoud R, Murphy JR, Perez N. Imported Congenital Rubella Syndrome, United States, 2017. Emerg Infect Dis. 2018;24(4):800-1. doi: 10.3201/eid2404.171540. PubMed PMID: 29553333; PMCID: PMC5875265.
American Board of Pediatrics, 2011
American Board of Pediatrics, Pediatric Infectious Diseases 2019